Compliance with tamoxifen in women with breast cancer and a BRCA1 or BRCA2 mutation

J Clin Oncol. 2010 Nov 20;28(33):e698-9; author reply e700. doi: 10.1200/JCO.2010.31.5770. Epub 2010 Oct 4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics
  • Female
  • Genes, BRCA1*
  • Genes, BRCA2*
  • Humans
  • Medication Adherence*
  • Mutation
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen